MVIS US Listed Pharmaceutical 25 Index

The MVIS US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, and marketing and sales.

Key Features

Size and Liquidity Requirements Full MCap of at least 150 mln USD.
Three month average-daily-trading volume of at least 1 mln USD at a review and also at the previous two reviews.
At least 250,000 shares traded per month over the last six months at a review and also at the previous two reviews.
Pure-Play Companies have to generate at least 50% revenues from pharmaceuticals.
Diversification Company weightings are capped at 20%.
Review Semi-annually.
IndexLast CloseOpenLastChangeChange (1Y)Range (1Y)
 
2,292.98 2,292.98 --24.52%1,487.10 - 2,422.79
 
3,421.61 3,421.61 --35.55%2,166.91 - 3,609.63
 
2,808.09 2,808.09 --38.14%1,763.80 - 2,961.14
Symbol IndexName
MVPPH MVIS US Pharmaceutical 25 Price Index
MVPPHTR MVIS US Pharmaceutical 25 Total Return Net Index
MVPPHTRG MVIS US Pharmaceutical 25 Total Return Gross Index
Up